References
- Amico, K. R., & Bekker, L.-G. (2019). Global PrEP roll-out: Recommendations for programmatic success. The Lancet HIV, 6(2), e137–e140. https://doi.org/10.1016/S2352-3018(19)30002-5
- Bekker, L., Gill, K., & Wallace, M. (2015). Pre-exposure prophylaxis for South African adolescents: What evidence? South African Medical Journal, 105(11), 907–911. https://doi.org/10.7196/SAMJ.2015.v105i11.10222
- Celum, C. L., Delany-Moretlwe, S., Baeten, J. M., Straten, A., Hosek, S., Bukusi, E. A., McConnell, M., Barnabas, R. V., & Bekker, L. (2019). HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: From efficacy trials to delivery. Journal of the International AIDS Society, 22(S4), e25298. https://doi.org/10.1002/jia2.25298
- Cluver, L., Toska, E., Orkin, F., Meinck, F., Hodes, R., Yakubovich, A., & Sherr, L. (2016). Achieving equity in HIV-treatment outcomes: Can social protection improve adolescent ART-adherence in South Africa? AIDS Care, 28(sup2), 73–82. https://doi.org/10.1080/09540121.2016.1179008
- Corneli, A. L., McKenna, K., Headley, J., Ahmed, K., Odhiambo, J., Skhosana, J., Wang, M., & Agot, K. (2014). A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa. Journal of the International AIDS Society, 17(3(Suppl 2)), 19152. https://doi.org/10.7448/IAS.17.3.19152
- Corneli, A., Perry, B., McKenna, K., Agot, K., Ahmed, K., Taylor, J., Malamatsho, F., Odhiambo, J., Skhosana, J., & Van Damme, L. (2016). Participants’ explanations for nonadherence in the FEM-PrEP clinical trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 71(4), 452–461. https://doi.org/10.1097/QAI.0000000000000880
- Corneli, A., Wang, M., Agot, K., Ahmed, K., Lombaard, J., Van Damme, L., & FEM-PrEP Study Group. (2014). Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP. JAIDS Journal of Acquired Immune Deficiency Syndromes, 67(5), 555–563. https://doi.org/10.1097/QAI.0000000000000362
- Cowan, F. M., Delany-Moretlwe, S., Sanders, E. J., Mugo, N. R., Guedou, F. A., Alary, M., Behanzin, L., Mugurungi, O., & Bekker, L.-G. (2016). PrEP implementation research in Africa: What is new? Journal of the International AIDS Society, 19(7(Suppl 6)), 21101–21101. https://doi.org/10.7448/IAS.19.7.21101
- Delavande, A., & Kohler, H.-P. (2009). Subjective expectations in the context of HIV/AIDS in Malawi. Demographic Research, 20, 817–875. https://doi.org/10.4054/DemRes.2009.20.31
- Delavande, A., & Kohler, H.-P. (2015). HIV/AIDS-related expectations and risky sexual behaviour in Malawi. The Review of Economic Studies, 83(1), 118–164. https://doi.org/10.1093/restud/rdv028
- Ding, Y., Yan, H., Ning, Z., Cai, X., Yang, Y., Pan, R., Zhou, Y., Zheng, H., Gao, M., Rou, K., Wu, Z., & He, N. (2016). Low willingness and actual uptake of pre-exposure prophylaxis for HIV-1 prevention among men who have sex with men in Shanghai, China. Bioscience Trends, 10(2), 113–119. https://doi.org/10.5582/bst.2016.01035
- Fonner, V. A., Dalglish, S. L., Kennedy, C. E., Baggaley, R., O’Reilly, K. R., Koechlin, F. M., Rodolph, M., Hodges-Mameletzis, I., & Grant, R. M. (2016). Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. Aids (london, England), 30(12), 1973–1983. https://doi.org/10.1097/QAD.0000000000001145
- Garfinkel, D. B., Alexander, K. A., McDonald-Mosley, R., Willie, T. C., & Decker, M. R. (2017). Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients. AIDS Care, 29(6), 751–758. https://doi.org/10.1080/09540121.2016.1234679
- Glidden, D. V., Amico, K. R., Liu, A. Y., Hosek, S. G., Anderson, P. L., Buchbinder, S. P., McMahan, V., Mayer, K. H., David, B., Schechter, M., Grinsztejn, B., Guanira, J., & Grant, R. M. (2016). Symptoms, side effects and adherence in the iPrEx Open-Label Extension. Clinical Infectious Diseases, 62(9), 1172–1177. https://doi.org/10.1093/cid/ciw022
- Gross, R., Bandason, T., Langhaug, L., Mujuru, H., Lowenthal, E., & Ferrand, R. (2015). Factors associated with self-reported adherence among adolescents on antiretroviral therapy in Zimbabwe. AIDS Care, 27(3), 322–326. https://doi.org/10.1080/09540121.2014.969676
- Hoots, B. E., Finlayson, T., Nerlander, L., Paz-Bailey, G., Group, N. H. B. S. S., Wortley, P., & German, D. (2016). Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men—20 US cities, 2014. Clinical Infectious Diseases, 63(5), 672–677. https://doi.org/10.1093/cid/ciw367
- Khawcharoenporn, T., Kendrick, S., & Smith, K. (2012). HIV risk perception and preexposure prophylaxis interest among a heterosexual population visiting a sexually transmitted infection clinic. AIDS Patient Care And Stds, 26(4), 222–233. https://doi.org/10.1089/apc.2011.0202
- Kidman, R., Piccolo, L. R., & Kohler, H.-P. (2019). Adverse childhood experiences: Prevalence and association with adolescent health in Malawi. American Journal of Preventive Medicine, 58(2), 285–293. https://doi.org/10.1016/j.amepre.2019.08.028.
- Kirby, T. (2016). Targeting HIV prevention to young women in Africa. The Lancet, 388(10060), 2579. https://doi.org/10.1016/S0140-6736(16)32385-6
- Koechlin, F. M., Fonner, V. A., Dalglish, S. L., O’Reilly, K. R., Baggaley, R., Grant, R. M., Rodolph, M., Hodges-Mameletzis, I., & Kennedy, C. E. (2017). Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: A systematic review of the literature. AIDS and Behavior, 21(5), 1325–1335. https://doi.org/10.1007/s10461-016-1627-z
- Kohler, H.-P., Watkins, S. C., Behrman, J. R., Anglewicz, P., Kohler, I. V., Thornton, R. L., Mkandawire, J., Honde, H., Hawara, A., Chilima, B., Bandawe, C., Mwapasa, V., Fleming, P., & Kalilani-Phiri, L. (2015). Cohort profile: The Malawi longitudinal study of families and health (MLSFH). International Journal of Epidemiology, 44(2), 394–404. https://doi.org/10.1093/ije/dyu049
- Landovitz, R. J., Kofron, R., & McCauley, M. (2016). The promise and pitfalls of long-acting injectable agents for HIV prevention. Current Opinion in HIV and AIDS, 11(1), 122–128. https://doi.org/10.1097/COH.0000000000000219
- Liu, A., Cohen, S., Follansbee, S., Cohan, D., Weber, S., Sachdev, D., & Buchbinder, S. (2014). Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Medicine, 11(3), e1001613. https://doi.org/10.1371/journal.pmed.1001613
- Mack, N., Evens, E. M., Tolley, E. E., Brelsford, K., Mackenzie, C., Milford, C., Smit, J. A., & Kimani, J. (2014). The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: A qualitative study. Journal of the International AIDS Society, 17(3(Suppl 2)), 19157. https://doi.org/10.7448/IAS.17.3.19157
- Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., Hendrix, C. W., Dai, J. Y., Ganesh, S., Mkhize, B., Taljaard, M., Parikh, U. M., Piper, J., Mâsse, B., Grossman, C., … Chirenje, Z. M. (2015). Tenofovir-based preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 372(6), 509–518. https://doi.org/10.1056/NEJMoa1402269
- Mathur, S., Pilgrim, N., & Pulerwitz, J. (2016). PrEP introduction for adolescent girls and young women. The Lancet HIV, 3(9), e406–e408. https://doi.org/10.1016/S2352-3018(16)30115-1
- Minnis, A. M., Roberts, S. T., Agot, K., Weinrib, R., Ahmed, K., Manenzhe, K., Owino, F., & van der Straten, A. (2018). Young women’s ratings of three placebo multipurpose prevention technologies for HIV and Pregnancy prevention in a randomized, cross-over study in Kenya and South Africa. AIDS and Behavior, 22(8), 2662–2673. https://doi.org/10.1007/s10461-018-2078-5
- Nachega, J. B., Hislop, M., Nguyen, H., Dowdy, D. W., Chaisson, R. E., Regensberg, L., Cotton, M., & Maartens, G. (2009). Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in Southern Africa. Journal of Acquired Immune Deficiency Syndromes (1999), 51(1), 65–71. https://doi.org/10.1097/QAI.0b013e318199072e
- NSO, N. S. O. M. (2017). 2015-16 Malawi Demographic and Health Survey Key Findings.
- Pilgrim, N., Mathur, S., Gottert, A., Rutenberg, N., & Pulerwitz, J. (2016). Building evidence to guide PrEP introduction for adolescent girls and young women. Population Council.
- PrEP Watch. (2018). Ongoing and Planned PrEP Open Label, Demonstration and Implementation Projects in Malawi. https://www.prepwatch.org/resource/malawi-prep-studies/
- Price, J. T., Rosenberg, N. E., Vansia, D., Phanga, T., Bhushan, N. L., Maseko, B., Brar, S. K., Hosseinipour, M. C., Tang, J. H., Bekker, L.-G., & Pettifor, A. (2018). Predictors of HIV, HIV risk perception, and HIV worry among adolescent girls and young women in Lilongwe, Malawi. Journal of Acquired Immune Deficiency Syndromes (1999), 77(1), 53–63. https://doi.org/10.1097/QAI.0000000000001567
- Saul, J., Bachman, G., Allen, S., Toiv, N. F., Cooney, C., Beamon, T. A., & Bekker, L.-G. (2018). The DREAMS core package of interventions: A comprehensive approach to preventing HIV among adolescent girls and young women. PLoS ONE, 13(12), e0208167–e0208167. https://doi.org/10.1371/journal.pone.0208167
- United Nations Children's Fund. (2018). Women: At the heart of the. HIV response for children. https://www.unicef.org/hiv/hiv-women-heart-of-response
- Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R., Onyango, J., Temu, L., Monedi, M. C., Mak'Oketch, P., Makanda, M., Reblin, I., Makatu, S. E., Saylor, L., Kiernan, H., Kirkendale, S., … Taylor, D. (2012). Preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 367(5), 411–422. https://doi.org/10.1056/NEJMoa1202614
- Van der Elst, E. M., Mbogua, J., Operario, D., Mutua, G., Kuo, C., Mugo, P., Kanungi, J., Singh, S., Haberer, J., Priddy, F., & Sanders, E. J. (2013). High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: Qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS and Behavior, 17(6), 2162–2172. https://doi.org/10.1007/s10461-012-0317-8
- Willie, T. C., Stockman, J. K., Overstreet, N. M., & Kershaw, T. S. (2018). Examining the impact of intimate partner violence type and timing on pre-exposure prophylaxis awareness, interest, and Coercion. AIDS and Behavior, 22(4), 1190–1200. https://doi.org/10.1007/s10461-017-1901-8
- Witte, T. H., & Kendra, R. (2010). Risk recognition and intimate partner violence. Journal of Interpersonal Violence, 25(12), 2199–2216. https://doi.org/10.1177/0886260509354880
- World Health Organization. (2005). Multi-Country Study on Women's Health and Domestic Violence against Women Initial results on prevalence, health outcomes and women's responses.
- Yi, S., Tuot, S., Mwai, G. W., Ngin, C., Chhim, K., Pal, K., Igbinedion, E., Holland, P., Choub, S. C., & Mburu, G. (2017). Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low-and middle-income countries: A systematic review and meta-analysis. Journal of the International AIDS Society, 20(1), 21580. https://doi.org/10.7448/IAS.20.1.21580
- Yun, K., Xu, J. J., Zhang, J., Li, J. M., Hu, Q. H., Chu, Z. X., Jiang, Y. J., Geng, W. Q., Shang, H., & Wang, N. (2018). Female and younger subjects have lower adherence in PrEP trials: A meta-analysis with implications for the uptake of PrEP service to prevent HIV. Sexually Transmitted Infections, 94(3), 163–168. https://doi.org/10.1136/sextrans-2017-053217%J